» Articles » PMID: 28484077

Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis Via Recruitment and Activation of Macrophages

Overview
Journal Cancer Res
Specialty Oncology
Date 2017 May 10
PMID 28484077
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic inflammation induced by persistent microbial infection plays an essential role in tumor progression. Although it is well documented that Epstein-Barr virus (EBV) infection is closely associated with nasopharyngeal carcinoma (NPC), how EBV-induced inflammation promotes NPC progression remains largely unknown. Here, we report that tumor infiltration of tumor-associated macrophages (TAM) and expression of CCL18, the cytokine preferentially secreted by TAM, closely correlate with serum EBV infection titers and tumor progression in two cohorts of NPC patients. compared with EBV NPC cell lines, EBV NPC cell lines exhibited superior capacity to attract monocytes and skew them to differentiate to a TAM-like phenotype. Cytokine profiling analysis revealed that NPC cells with active EBV replications recruited monocytes by VEGF and induced TAM by GM-CSF in an NF-κB-dependent manner. Reciprocally, TAM induced epithelial-mesenchymal transition and furthered NF-κB activation of tumor cells by CCL18. In humanized mice, NPC cells with active EBV replications exhibited increased metastasis, and neutralization of CCL18, GM-CSF, and VEGF significantly reduced metastasis. Collectively, our work defines a feed-forward loop between tumor cells and macrophages in NPC, which shows how metastatic potential can evolve concurrently with virus-induced chronic inflammation. .

Citing Articles

Multi-Omics Characterization of Genome-Wide Abnormal DNA Methylation Reveals FGF5 as a Diagnosis of Nasopharyngeal Carcinoma Recurrence After Radiotherapy.

Long Z, Ding R, Quan T, Xu R, Huang Z, Wei D Biomolecules. 2025; 15(2).

PMID: 40001587 PMC: 11853517. DOI: 10.3390/biom15020283.


Hip metastasis presenting as anterior knee pain from nasopharyngeal carcinoma: A case report.

Lang J, Xiong Z Oncol Lett. 2025; 29(4):165.

PMID: 39944789 PMC: 11811695. DOI: 10.3892/ol.2025.14911.


Targeting of TAMs: can we be more clever than cancer cells?.

Kzhyshkowska J, Shen J, Larionova I Cell Mol Immunol. 2024; 21(12):1376-1409.

PMID: 39516356 PMC: 11607358. DOI: 10.1038/s41423-024-01232-z.


EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment.

Xiang T, Sun F, Liu T, Zhao J, Yang J, Ouyang D Theranostics. 2024; 14(13):5123-5140.

PMID: 39267775 PMC: 11388080. DOI: 10.7150/thno.100171.


Characterization of unique pattern of immune cell profile in patients with nasopharyngeal carcinoma through flow cytometry and machine learning.

Liao L, Tsai C, Li P, Lee C, Lin S, Lai W J Cell Mol Med. 2024; 28(12):e18404.

PMID: 38888489 PMC: 11184936. DOI: 10.1111/jcmm.18404.